* LENSAR Inc reported a quarterly adjusted loss of 79 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of -81 cents. The mean expectation of two analysts for the quarter was for a loss of 29 cents per share. Wall Street expected results to range from -30 cents to -29 cents per share.
* Revenue rose 5.2% to $12.64 million from a year ago; analysts expected $12.15 million.
* LENSAR Inc's reported EPS for the quarter was a loss of 79 cents.
* The company reported a quarterly loss of $9.05 million.
* LENSAR Inc shares had fallen by 1.6% this quarter and gained 26.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for LENSAR Inc is $8.00 This summary was machine generated from LSEG data August 8 at 01:52 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.29 -0.79 Missed
Mar. 31 2024 -0.28 -0.19 Beat
Dec. 31 2023 -0.22 -0.35 Missed
Sep. 30 2023 -0.34 -0.23 Beat
Comments